Biotech

All Articles

' Scientific instinct' led FDA advisors to back Zevra's unusual condition med

.Zevra Therapeutics' rare illness drug seems to be to be on the pathway to confirmation this fall af...

Pfizer takes $230M attacked after axing failed DMD genetics therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) gene therapy failing has actually blown a $230 t...

AC Immune sees 'site' possible in Alzheimer's medicine records

.After much more than twenty years of service neurodegenerative illness, Swiss biotech a/c Immune cl...

GSK loses ph. 2 HPV vaccination over lack of best-in-class possible

.GSK has junked a period 2 human papillomavirus (HPV) vaccine coming from its own pipeline after cho...

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will certainly provide on the NYSE American supply substitution this mor...

ALX's fizzling CD47 feedback fee delivers inventory spiraling down

.ALX Oncology's phase 2 stomach cancer action cost has damaged. After seeing its CD47 blocker effort...

Ionis centers eye condition from aim ats of Roche-partnered prospect after records dissatisfy

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed assumptio...

Biogen's chief executive officer pointed out no unsafe sell 2023. He prepares to be vibrant

.While Biogen's pharma peers are actually looking for late-stage properties along with little risk, ...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech looking for a pipe after it scrapped its lead...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually handed back legal rights to an early Alzheimer's health condition course to Den...